...
首页> 外文期刊>BMC Psychiatry >Assessing the prevalence of non-medical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used
【24h】

Assessing the prevalence of non-medical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used

机译:评估加拿大普通成人中非医疗类阿片类药物的使用率:根据所使用的调查问题,差异很大

获取原文

摘要

Background Morbidity and mortality related to Prescription Opioid Analgesics (POAs) have been rising sharply in North America. Non-Medical Prescription Opioid Use (NMPOU) in the general population is a key indicator of POA-related harm, yet the role of question item design for best NMPOU prevalence estimates in general population surveys is unclear, and existing NMPOU survey data for Canada are limited. Methods We tested the impact of different NMPOU question items by comparing an item in the 2008 and 2009 (N?=?2,017) samples of the CAMH Monitor surveys – an Ontario adult general population survey – with a newly developed item used in the 2010 (N?=?2,015) samples of the Centre for Addiction and Mental Health (CAMH) Monitor surveys. To control for a potential difference in the population demographics between surveys, we adjusted for gender, age, region, income, prescription opioid use, cigarette smoking, weekly binge drinking, cannabis use in the past three months, and psychological distress in our analyses. Results The prevalence of NMPOU as measured by the 2008 and 2009 CAMH monitor (2.0% [95% CI: 1.2% to 2.8%]) was significantly different when compared to the prevalence of NMPOU as measured by the 2010 CAMH monitor (7.7% [95% CI: 6.3% to 9.2%]) (p? Conclusion It is highly unlikely that the extensive NMPOU prevalence differences observed from the different survey items reflect an actual increase of NMPOU or changes in NMPOU determinants, but rather point to measurement effects. It appears that we currently do not have accurate estimates of NMPOU in the Canadian general population, even though these estimates are needed to guide and implement targeted interventions. Given the current substantial morbidity and mortality impact of NMPOU, there is an urgent need to systematically develop, validate and standardize NMPOU items for future general population surveys in Canada.
机译:背景技术与处方阿片类镇痛药(POA)有关的发病率和死亡率在北美急剧上升。普通人群中的非医学处方阿片类药物使用(NMPOU)是与POA相关的伤害的关键指标,但是尚不清楚用于一般人群调查中最佳NMPOU患病率估计的问题项目设计的作用,加拿大的现有NMPOU调查数据是有限。方法我们通过比较CAMH Monitor调查的2008年和2009年(N?=?2,017)样本(安大略成人总人口调查)中的一个项目与2010年使用的新开发的项目(成瘾和心理健康中心(CAMH)监控调查的样本为N?=?2,015)。为了控制两次调查之间人口统计学的潜在差异,我们对性别,年龄,地区,收入,处方阿片类药物使用,吸烟,每周暴饮暴食,过去三个月中的大麻使用以及我们的分析中的心理困扰进行了调整。结果2008年和2009年CAMH监测器的NMPOU患病率(2.0%[95%CI:1.2%至2.8%])与2010年CAMH监测器的NMPOU患病率(7.7%[ 95%CI:6.3%到9.2%](p?结论)从不同的调查项目中观察到的NMPOU普遍流行率差异不太可能反映NMPOU的实际增加或NMPOU决定因素的变化,而是指出测量效果。尽管目前尚无准确的估计来指导和实施有针对性的干预措施,但加拿大目前仍没有准确的NMPOU估算值,鉴于目前NMPOU的高发病率和死亡率影响,迫切需要系统地制定,验证和标准化NMPOU项目,以供将来在加拿大进行的一般人口调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号